B
United Therapeutics Corporation UTHR
$322.94 $15.705.11%
Recommendation
Buy
Prev Close
$307.24
Volume
400,603
Avg Vol (90D)
393,778
Market Cap
$13.80B
Dividend & Yield
--
52-Week Range
$221.53 - $417.82
P/E (TTM)
12.49
EPS (TTM)
$24.59
My Lists My Alerts
Rating
Reward
B
Good
Risk
C
Fair
Rating Factors
Growth Index
Excellent
Efficiency Index
Excellent
Solvency Index
Excellent
Total Return Index
Fair
Volatility Index
Fair
Dividend Index
--
Headlines
United Therapeutics Insiders Sell US$7.1m Of Stock, Possibly Signalling Caution
3/17/2025 - Simply Wall St
Brandes Investment Partners LP Has $524,000 Stock Position in United Therapeutics Co. (NASDAQ:UTHR)
3/17/2025 - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Boosts Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR)
3/17/2025 - MarketBeat
Globeflex Capital L P Trims Stock Position in United Therapeutics Co. (NASDAQ:UTHR)
3/16/2025 - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) Stake Lessened by Skandinaviska Enskilda Banken AB publ
3/15/2025 - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) Shares Purchased by Erste Asset Management GmbH
3/15/2025 - MarketBeat
Achmea Investment Management B.V. Has $12.97 Million Position in United Therapeutics Co. (NASDAQ:UTHR)
3/15/2025 - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) Receives Consensus Recommendation of "Moderate Buy" from Analysts
3/15/2025 - MarketBeat
Is United Therapeutics Corporation (UTHR) the Best Healthcare Stock For Long-Term Investment?
3/14/2025 - Insider Monkey
Amundi Has $42.97 Million Stake in United Therapeutics Co. (NASDAQ:UTHR)
3/13/2025 - MarketBeat
United Therapeutics (UTHR, $304.42) RSI Indicator left the oversold zone on March 11, 2025
3/12/2025 - Tickeron - Stocks
United Therapeutics Larger Than S&P 500 Component First Solar
3/11/2025 - The Online Investor
Ruffer LLP Invests $4.04 Million in United Therapeutics Co. (NASDAQ:UTHR)
3/10/2025 - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by E Fund Management Co. Ltd.
3/8/2025 - Ticker Report
State of Michigan Retirement System Sells 300 Shares of United Therapeutics Co. (NASDAQ:UTHR)
3/8/2025 - Ticker Report
Analyst Favorites With Strong Buyback Activity: United Therapeutics Ranks As a Top Pick
3/7/2025 - The Online Investor
Victory Capital Management Inc. Grows Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR)
3/7/2025 - Ticker Report
Candriam S.C.A. Grows Position in United Therapeutics Co. (NASDAQ:UTHR)
3/7/2025 - MarketBeat
We Did The Math TPLC Can Go To $50
3/6/2025 - ETF Channel
Plato Investment Management Ltd Sells 645 Shares of United Therapeutics Co. (NASDAQ:UTHR)
3/5/2025 - Ticker Report
Seizert Capital Partners LLC Acquires 1,312 Shares of United Therapeutics Co. (NASDAQ:UTHR)
3/5/2025 - MarketBeat
Assetmark Inc. Boosts Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR)
3/5/2025 - MarketBeat
United Therapeutics Corp (UTHR) Announces Participation in Leerink Partners Global Healthcare ...
3/4/2025 - GuruFocus
United Therapeutics Corporation to Present at the Leerink Partners Global Healthcare Conference 2025
3/4/2025 - GuruFocus
United Therapeutics Corporation to Present at the Leerink Partners Global Healthcare Conference 2025
3/4/2025 - Business Wire
Income Statement
Total Revenue (TTM)
$2.88B
EBITDA (TTM)
$1.52B
EBIT (TTM)
$1.45B
Net Income (TTM)
$1.20B
Balance Sheet
Total Assets (Q)
$7.36B
Total Debt (Q)
$338.60M
Total Liabilities (Q)
$920.00M
Book Value Per Share (Q)
$143.74
Cash Flow
Cash from Operations (TTM)
$1.33B
Cash from Investing (TTM)
$417.20M
Cash from Financing (TTM)
-$1.25B
Net Change in Cash (TTM)
$489.50M
Filings
Filing Date
Wednesday, February 26, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Beginning of May (est)
Price History
Loading...
Beta
0.94
7-Day Total Return
4.96%
30-Day Total Return
-8.04%
60-Day Total Return
-13.38%
90-Day Total Return
-13.66%
Year to Date Total Return
-10.35%
1-Year Total Return
36.97%
2-Year Total Return
48.48%
3-Year Total Return
80.60%
5-Year Total Return
306.57%
52-week Low
Apr 01, 2024 - $221.53
52-week High
Nov 08, 2024 - $417.82
Valuation
Market Cap
$13.80B - Large Cap
Enterprise Value
$9.40B
Price/Sales (TTM)
5.20
Price/Book (Q)
2.14
Dividends and Shares
Shares Outstanding
48.70M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.unither.com
Phone Number
301 608 9292
Address
1000 Spring Street
Silver Spring, MD 20910
Country
United States
Year Founded
1996
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and... more
NASDAQ 03/17/2025 4:00PM Eastern Quotes delayed
Weiss Ratings